Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Therapeutics, Inc.

Heron Therapeutics focuses on developing medicines aimed at addressing unmet medical needs in oncology care and acute pain management. self-described as unwavering in their commitment to improve patients' lives.

COM:HERONTX

Heron Therapeutics

Last Close

1.06

22/11 21:00

Market Cap

162.74M

Beta: -

Volume Today

1.34M

Avg: -